| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/EUROPACE/EUU128 |
| P698 | PubMed publication ID | 24938629 |
| P50 | author | Lorenzo Monserrat | Q42794375 |
| Mariano Valdés Chávarri | Q102078444 | ||
| Francisco Ruiz-Espejo | Q117261821 | ||
| P2093 | author name string | Josefa González-Carrillo | |
| Juan R Gimeno | |||
| Juan José Sánchez Muñoz | |||
| David López-Cuenca | |||
| Ivan Gómez-Milanés | |||
| Jose María López-Ayala | |||
| M J Oliva-Sandoval | |||
| Martín Ortíz | |||
| P2860 | cites work | Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q24299388 |
| Are desmosomes more than tethers for intermediate filaments? | Q28205062 | ||
| Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice | Q28279991 | ||
| Sudden cardiac death in young people with apparently normal heart | Q33146371 | ||
| Dispersion of ventricular depolarization-repolarization: a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy | Q33146513 | ||
| Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. | Q33150735 | ||
| Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations | Q33152773 | ||
| Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study. | Q33161166 | ||
| Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. | Q33162348 | ||
| Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. | Q33547357 | ||
| Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria | Q33764619 | ||
| Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? | Q34395507 | ||
| ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the | Q34640762 | ||
| Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy | Q35382044 | ||
| Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy | Q36330386 | ||
| Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance | Q38520098 | ||
| Risk stratification of sudden cardiac death and malignant ventricular arrhythmias in right ventricular dysplasia-cardiomyopathy | Q43615832 | ||
| Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy | Q46630214 | ||
| Screening of genes encoding junctional candidates in arrhythmogenic right ventricular cardiomyopathy/dysplasia | Q48000354 | ||
| Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. | Q51704331 | ||
| A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. | Q51772909 | ||
| P433 | issue | 12 | |
| P921 | main subject | cardiomyopathy | Q847583 |
| P304 | page(s) | 1838-1846 | |
| P577 | publication date | 2014-06-17 | |
| P1433 | published in | EP Europace | Q2596718 |
| P1476 | title | Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype | |
| P478 | volume | 16 |
| Q89951257 | A mutation update for the FLNC gene in myopathies and cardiomyopathies |
| Q49464137 | Application of Single-Nucleotide Polymorphism-Related Risk Estimates in Identification of Increased Genetic Susceptibility to Cardiovascular Diseases: A Literature Review |
| Q33167672 | Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes |
| Q92740412 | Arrhythmogenic Left Ventricular Cardiomyopathy: A Clinical and CMR Study |
| Q90577852 | Arrhythmogenic left ventricular cardiomyopathy |
| Q89471253 | DSP p.(Thr2104Glnfs*12) variant presents variably with early onset severe arrhythmias and left ventricular cardiomyopathy |
| Q64883533 | Desmoplakin maintains gap junctions by inhibiting Ras/MAPK and lysosomal degradation of connexin-43. |
| Q27013675 | Desmosome regulation and signaling in disease |
| Q64944906 | Genetics of and pathogenic mechanisms in arrhythmogenic right ventricular cardiomyopathy. |
| Q58121782 | Genotype-Positive Status Is Associated With Poor Prognoses in Patients With Left Ventricular Noncompaction Cardiomyopathy |
| Q93094672 | Importance of Genetic Testing in Dilated Cardiomyopathy: Applications and Challenges in Clinical Practice |
| Q41776920 | Nature and Nurture in Arrhythmogenic Right Ventricular Cardiomyopathy - A Clinical Perspective |
| Q89661633 | Next-generation sequencing identified novel Desmoplakin frame-shift variant in patients with Arrhythmogenic cardiomyopathy |
| Q38922797 | Pathophysiology of the Desmo-Adhesome |
| Q92718026 | Patient mutations linked to arrhythmogenic cardiomyopathy enhance calpain-mediated desmoplakin degradation |
| Q38666336 | Precision medicine approach to genetic cardiomyopathy |
| Q97548546 | Sudden Cardiac Death Prediction in Non-ischemic Dilated Cardiomyopathy: a Multiparametric and Dynamic Approach |
| Q64230001 | Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy |
Search more.